fda on tirzepatide 🚨 Generic Versions of Mounjaro & Zepbound Move Closer as Reviews First Applications The US Food and Drug Administration (FDA) is reviewing the first applications for generic versions of Eli Lilly's FDA Faces Law Suit Over

Side Effect and Shot Rotation Monitoring Pep: GLP-1 medications can have side effects, and Pep includes a feature to log and monitor them

The Real-Bari study, launched on June 26, 2026, at the Grupo Hospitalar Conceio in Porto Alegre, Rio Grande do Sul, is enrolling 250 patients with severe obesity over a two-year period to evaluate effectiveness, safety, and cost

A Although the substances in the injections may play important roles in fat metabolism, researchers are still unclear whether higher doses are beneficial for weight or fat loss and lipotropic injections may not be effective for weight or fat reduction

Zepbound vs Wegovy: Which Weight Loss Medication Is Right for You